Physician profile
Jivianne K Lee
NPI 1184772972
$324,365.18
in general payments reported to CMS, 2019-2025
26 companies · $76K in 2025
The $76K reported for 2025 was more than what 99% of Plastic Surgery Within The Head & Neck providers received nationally (typical 2025 total: $238).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $42K · 2020: $30K · 2021: $49K · 2022: $39K · 2023: $46K · 2024: $42K · 2025: $76K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $97K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $44K · Travel and Lodging: $18K · Food and Beverage: $5,575.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $96,800.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $43,835.00 |
| Travel and Lodging | $18,040.55 |
| Food and Beverage | $5,575.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $72,568.70 | 2021-2025 | Straightshot, Endo-Scrub, Fusion |
| Stryker Corporation | $64,549.34 | 2019-2025 | Xpress Ent Dilation System, Scopis Ent, Clarifix Cryotherapy Device |
| Aerin Medical INC. | $41,361.15 | 2019-2025 | |
| Glaxosmithkline, LLC. | $30,039.24 | 2024-2025 | Nucala |
| Genzyme Corporation | $28,402.20 | 2019-2022 | |
| Intersect Ent, INC. | $24,184.33 | 2019-2021 | |
| Olympus Corporation of The Americas | $17,155.97 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $17,072.73 | 2019-2023 | Dupixent |
| Sanofi-Aventis U.S. LLC | $15,953.63 | 2023 | |
| Smith+Nephew, INC. | $4,802.93 | 2019-2024 | |
| Medtronic USA, INC. | $2,697.88 | 2019-2020 | |
| Acclarent, INC | $1,851.46 | 2019-2023 | Trudi Nav Cable |
| Optinose US, INC. | $701.76 | 2019-2021 | |
| Neurent Medical Limited | $559.24 | 2022-2025 | Neuromark Radiofrequency Console, Neuromark Device, Neuromark System |
| Olympus Corporation | $510.00 | 2019 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $316.24 | 2023-2024 | Integra, Integra Duo, Codman Isocool Aht |
| Verathon INC. | $300.00 | 2019 | |
| Musculoskeletal Transplant Foundation INC. | $262.58 | 2024 | |
| Astrazeneca Pharmaceuticals Lp | $210.89 | 2025 | |
| Karl Storz Endoscopy-America | $186.76 | 2022 | |
| Regeneron Pharmaceuticals, INC. | $150.00 | 2025 | Dupixent |
| Becton, Dickinson and Company | $137.90 | 2022 | |
| Boston Scientific Corporation | $122.09 | 2019 | |
| Novartis Pharmaceuticals Corporation | $100.73 | 2020 | |
| Depuy Synthes Sales INC. | $100.04 | 2019 | |
| Cook Medical LLC | $67.39 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jivianne Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.